BackCytoMed Therapeutics Overview

CytoMed Therapeutics Total Revenue

Revenue analysis for GDTC.

Quarterly Revenue

$130625.00
↑ 149.21% YoY

As of Dec 2025

Annual Revenue (TTM)

$388788.00

Trailing 12 months ending Dec 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin